November 2, 2021 Philips debuts three new solutions in the North American market that will help drive procedural innovation and workflow efficiency, adding to the company's ecosystem of interventional
Investegate announcements from Royal Philips, TCT 2021: Philips announces new innovations and clinical data supporting the treatment of patients with cardiovascular disease
The clinical benefits of initial invasive management came with a minimal increased risk of in-hospital acute kidney injury and major bleeding in a large dataset analysis.
E-Mail
DALLAS, Jan. 14, 2021 The longer the time between when heart attack symptoms start and a patient has an artery-clearing percutaneous coronary intervention (PCI), the more damage to the heart muscle, according to new research published today in
Circulation: Cardiovascular Interventions, an American Heart Association journal.
A heart attack happens about every 40 seconds in the U.S., and the most common heart attack is caused by a complete blockage in a coronary artery, called ST-elevation myocardial infarction (STEMI). STEMI patients are most often treated with PCI, also known as angioplasty with stent, in which a catheter with a deflated balloon is inserted into the narrowed heart artery. Subsequently, the balloon is inflated, which clears the obstruction and restores blood flow. A stent is then inserted to keep the artery open.